an antineoplastic antibiotic used in the treatment of cancer
Examples of 'doxorubicin' in a sentence
doxorubicin
The most used regimen was doxorubicin in 25 patients (55.6%).
Leonardo Gomes da Fonseca, Guilherme Nader Marta, Maria Ignez Freitas Melro Braghiroli,Aline Lopes Chagas, Flair Jose Carrilho, Paulo Marcelo Hoff, Jorge Sabbaga 2018, 'Safety and efficacy of cytotoxic chemotherapy in hepatocellular carcinoma after first-linetreatment with sorafenib', BMC Cancerhttp://link.springer.com/article/10.1186/s12885-018-5173-0. Retrieved from DOAJ CC BY 4.0 (https://creativecommons.org/licenses/by-sa/4.0/legalcode)
All of these doxorubicin-induced effects were attenuated by oxymatrine.
Yan-Yan Zhang, Minhan Yi, Yong-Pan Huang 2017, 'Oxymatrine Ameliorates Doxorubicin-Induced Cardiotoxicity in Rats', Cellular Physiology and Biochemistryhttp://www.karger.com/Article/FullText/480471. Retrieved from DOAJ CC BY 4.0 (https://creativecommons.org/licenses/by-sa/4.0/legalcode)
Doxorubicin was employed as a positive control.
Manjunatha K. Siddappa, Manjulatha K, Nayak D. Satyanarayan, Kaviraj M. Yarbagi, AdarshaH. Jagadeesha 2016, 'Anti-proliferative and ADMET screening of novel 3-(1H-indol-3-yl)-1, 3-diphenylpropan-1-onederivatives', Cogent Chemistryhttp://dx.doi.org/10.1080/23312009.2016.1172542. Retrieved from DOAJ CC BY 4.0 (https://creativecommons.org/licenses/by-sa/4.0/legalcode)
Doxorubicin monotherapy was effective in this case.
Kazuhisa Tanaka, Takekazu Iwata, Kai Nishii, Yukiko Matsui, Tsukasa Yonemoto, HidetadaKawana, Makiko Itami, Shigetoshi Yoshida, Toshihiko Iizasa 2019, 'A case of primary pulmonary leiomyosarcoma completely resected after neoadjuvant chemotherapy',Surgical Case Reportshttp://link.springer.com/article/10.1186/s40792-019-0649-y. Retrieved from DOAJ CC BY 4.0 (https://creativecommons.org/licenses/by-sa/4.0/legalcode)
The patient was given four cycles of chemotherapy with cyclophosphamide, doxorubicin and docetaxol.
Lakshmi Sivarajan, Kulumani M. Sivarajan, Joseph Natarelli, Farrukh Aijaz 2011, 'Change in HER-2/neu Status from Negative to Positive following Treatment in BreastCancer: A Case Report', Case Reports in Oncologyhttp://www.karger.com/Article/FullText/324114. Retrieved from DOAJ CC BY 4.0 (https://creativecommons.org/licenses/by-sa/4.0/legalcode)
In this study, we evaluated anticancer properties of berberine in comparison to doxorubicin.
Elmira Barzegar, Shamileh Fouladdel, Tahereh Komeili Movahhed, Shekoufeh Atashpour,Mohammad Hossein Ghahremani, Seyed Nasser Ostad, Ebrahim Azizi 2015, 'Effects of berberine on proliferation, cell cycle distribution and apoptosis of humanbreast cancer T47D and MCF7 cell lines', Iranian Journal of Basic Medical Scienceshttp://ijbms.mums.ac.ir/pdf_4281_03069c2fad66a0908423c6b5e8de6723.html. Retrieved from DOAJ CC BY 4.0 (https://creativecommons.org/licenses/by-sa/4.0/legalcode)
Neoadjuvant chemo-endocrine therapy included four cycles of doxorubicin plus paclitaxel followed by weekly paclitaxel.
Sasagu Kurozumi, Yuri Yamaguchi, Hiroshi Matsumoto, Masafumi Kurosumi, Shin-Ichi Hayashi,Takaaki Fujii, Jun Horiguchi, Ken Shirabe, Kenichi Inoue 2019, 'Utility of Ki67 labeling index, cyclin D1 expression, and ER-activity level in postmenopausalER-positive and HER2-negative breast cancer with neoadjuvant chemo-endocrine therapy.',PLoS ONEhttp://europepmc.org/articles/PMC6528995?pdf=render. Retrieved from PLOS CC BY 4.0 (https://creativecommons.org/licenses/by-sa/4.0/legalcode)
The growth, migration, and sensitivity to doxorubicin were assessed.
José Luis Granados-Soler, Johannes Junginger, Marion Hewicker-Trautwein, Kirsten Bornemann-Kolatzki,Julia Beck, Bertram Brenig, Daniela Betz, Jan Torben Schille, Hugo Murua Escobar,Ingo Nolte 2018, 'TiHo-0906: a new feline mammary cancer cell line with molecular, morphological, andimmunocytological characteristics of epithelial to mesenchymal transition', Scientific Reportshttp://link.springer.com/article/10.1038/s41598-018-31682-1. Retrieved from DOAJ CC BY 4.0 (https://creativecommons.org/licenses/by-sa/4.0/legalcode)
Unlike doxorubicin, however, it exhibits little or no cardiotoxicity in clinical studies and preclinical models.
Christine Galustian, Victoria Sung, Blake Bartlett, Lindsey Rolfe, Angus Dalgleish 2010, 'Recent Pharmacological Advances: Focus on Small-cell Lung Cancer', Clinical Medicine Insights: Therapeuticshttps://doi.org/10.4137/CMT.S44. Retrieved from DOAJ CC BY 4.0 (https://creativecommons.org/licenses/by-sa/4.0/legalcode)